Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale

Grant, Peter E., Pampaka, Maria, Payne, Katherine, Clarke, Angus ORCID: https://orcid.org/0000-0002-1200-9286 and McAllister, Marion 2019. Developing a short-form of the Genetic Counselling Outcome Scale: The Genomics Outcome Scale. European Journal of Medical Genetics 62 (5) , pp. 324-334. 10.1016/j.ejmg.2018.11.015

Preview	PDF - Accepted Post-Print Version Download (283kB) | Preview
Preview	PDF - Supplemental Material Download (802kB) | Preview
Preview	Image (JPEG) (Figure 1) - Supplemental Material Download (252kB) | Preview
Preview	Image (JPEG) (Figure 2) - Supplemental Material Download (47kB) | Preview
Preview	Image (JPEG) (Figure 3) - Supplemental Material Download (29kB) | Preview
Preview	Image (JPEG) (Figure 4) - Supplemental Material Download (52kB) | Preview
Preview	Image (JPEG) (Figure 5) - Supplemental Material Download (67kB) | Preview

Abstract

The Genetic Counselling Outcome Scale (GCOS-24) is a 24-item patient reported outcome measure for use in evaluations of genetic counselling and testing services. The aim of this study was to develop a short form of GCOS-24. The study comprised three phases. Phase I: Cognitive interviews were used to explore interpretability of GCOS-24 items and which GCOS-24 items were most valued by the target population. Phase II: The Graded Response Model was used to analyse an existing set of GCOS-24 responses (n = 395) to examine item discrimination. Phase III: Item Selection. Three principles guided the approach to item selection (i) Items with poor discriminative properties were not selected; (ii) To avoid redundancy, items capturing a similar outcome were not selected together; item information curves and cognitive interview findings were used to establish superior items. (iii) Rasch analysis was then used to determine the optimal scale. In Phase I, ten cognitive interviews were conducted with individuals affected by or at risk for a genetic condition, recruited from patient support groups. Analysis of interview transcripts identified twelve GCOS-24 items which were highly valued by participants. In Phase II, Graded Response Model item characteristic curves and item information curves were produced. In Phase III, findings from Phases I and II were used to select ten highly-valued items that perform well. Finally, items were iteratively removed and permutated to establish optimal fit statistics under the Rasch model. A six-item questionnaire with a five-point Likert Scale was produced (The Genomics Outcome Scale (GOS)). Correlation between GCOS-24 and GOS scores is high (r = 0.838 at 99% confidence), suggesting that GOS maintains the ability of GCOS-24 to capture empowerment, whilst providing a less burdensome scale for respondents. This study represents the first step in developing a preference-based measure which could be used in the evaluation of technologies and services used in genomic medicine.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Elsevier
Date of First Compliant Deposit:	30 November 2018
Date of Acceptance:	19 November 2018
Last Modified:	06 Nov 2024 23:30
URI:	https://orca.cardiff.ac.uk/id/eprint/117256

Citation Data

Cited 20 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item